Study of the impact of ClinGen Revisions on ACMG/AMP variant semi-automatic classification for Rare Diseases diagnosis
Clinica Chimica Acta · 2025
DOI: 10.1016/j.cca.2024.120065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinica Chimica Acta, 2025. Verfasst von Ana Rius und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires (FCEyN-UBA) e Instituto de Química Biológica…. Hauptthemen laut MEDLINE: Rare Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: University of Buenos Aires Secretariat of Science and Technology.
Abstract (Originalsprache)
With the rapid development of massive sequencing technologies, the analysis of genetic variants for clinical diagnosis has exponentially escalated, particularly in the context of Rare Diseases (RDs). Diagnosing them involves identifying the genetic variants responsible for the underlying pathology development. In 2015, the American College of Medical Genetics (ACMG) established a set of recommendations to assess the evidence associated with each variant, aiming to achieve a standardized five tier classification. Over the past 5 years, ClinGen, the NIH-funded Clinical Genome Resource, has reviewed these criteria in order to make variant classification a more reproducible and rigorous process. This paper examines the impact of ClinGen-Rev modifications on variant classification, comparing them with the ACMG-2015 original recommendations. After analyzing sets of genetic variants, extracted from VCFs samples, using both criteria, we observed a change in 8.0 % of the clinical verdicts for these variants. ClinGen-Rev modifications correctly categorized 89.2 % of the curated variants, representing a significant improvement compared to the 65.6 % achieved by ACMG-2015. We also analyzed the modifications impact in a real like clinical setting, showing a significant overall reduction of VUS variants and thus potential reduction in analysis time. Finally, we discuss the underlying reasons for the most relevant changes in terms of specific labels and present their implications on the prioritization and selection process of variants, identifying some recommendations of key significant importance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires (FCEyN-UBA) e Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN) CONICET, P…
- Bitgenia, Análisis de Datos Genómicos, Camino Parque Centenario N° 2565 - La Plata, Alicia Moreau de Justo N° 1750 3° H - CABA, Buenos Aires, Argentina.
Förderung
- University of Buenos Aires Secretariat of Science and Technology
Zitieren
APA
Rius, A., Aguirre, N., Erra, L., Brunello, F. G., Biagioli, G., Zaiat, J., & Marti, M. A. (2025). Study of the impact of ClinGen Revisions on ACMG/AMP variant semi-automatic classification for Rare Diseases diagnosis. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2024.120065
Vancouver
Rius A, Aguirre N, Erra L, Brunello FG, Biagioli G, Zaiat J, et al. Study of the impact of ClinGen Revisions on ACMG/AMP variant semi-automatic classification for Rare Diseases diagnosis. Clinica Chimica Acta. 2025. doi:10.1016/j.cca.2024.120065
BibTeX
@article{Rius2025,
author = {Rius, Ana and Aguirre, Nicolas and Erra, Lorenzo and Brunello, Franco Gino and Biagioli, German and Zaiat, Jonathan and Marti, Marcelo A},
title = {Study of the impact of ClinGen Revisions on ACMG/AMP variant semi-automatic classification for Rare Diseases diagnosis},
journal = {Clinica Chimica Acta},
year = {2025},
doi = {10.1016/j.cca.2024.120065}
}
EUVIMED